Skip to main content
Premium Trial:

Request an Annual Quote

GenDx Receives Canadian License for HLA Typing Software

NEW YORK (GenomeWeb) – Dutch genetic testing firm GenDx announced on Wednesday that it has received a medical device license from Canadian regulators for its NGSengine human leukocyte antigen (HLA) typing software.

The software provides analyses of HLA typing by next-generation sequencing on several platforms, including Illumina's MiSeq, Thermo Fisher Scientific's IonTorrent PGM, and Pacific Biosciences' PacBio RSII. It includes whole-gene representation, automatic allele assignment and multi-loci analysis, and simultaneous genotyping of multiple HLA loci, as well as a variety of reviewing and reporting options. The software was CE marked in early 2016.

HLA genes code for cell-surface antigen-presenting proteins, and HLA typing is an important genetic analysis in assessing compatibility between donor and recipient in stem cell and solid organ transplants since mismatches can result in transplant failure.

"Next-generation sequencing is rapidly becoming the new gold standard for high resolution HLA typing due to its ease of use and capability to process large data volumes in short time," GenDx Cofounder and CEO Wietse Mulder said in a statement. "Powerful software is an essential step in determining the HLA alleles of both donor and patient. I am glad that our NGSengine package can fulfill this pivotal role in transplantation diagnostics."

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.